Cell Death and Disease (Aug 2021)

LncRNA coordinates Hippo and mTORC1 pathway activation in cancer

  • Shugeng Zhang,
  • Shuhang Liang,
  • Dehai Wu,
  • Hongrui Guo,
  • Kun Ma,
  • Lianxin Liu

DOI
https://doi.org/10.1038/s41419-021-04112-w
Journal volume & issue
Vol. 12, no. 9
pp. 1 – 11

Abstract

Read online

Abstract The Hippo and mammalian target of rapamycin complex 1 (mTORC1) pathways are the two predominant pathways that regulate tumour growth and metastasis. Therefore, we explored the potential crosstalk between these two functionally relevant pathways to coordinate their tumour growth-control functions. We found that a Hippo pathway-related long noncoding RNA, HPR, directly interacts with Raptor, an essential component of mTORC1, to upregulate mTORC1 activation by impairing the phosphorylation of Raptor by AMPK. Knockdown or knockout of HPR in breast cancer and cholangiocarcinoma cells led to a reduction in tumour growth. Compared with HPR WT cells, HPR-overexpressing cells exhibited nuclear accumulation of YAP1, and significantly blocked the downregulation of mTORC1 signalling induced by energy stress. Thus, our study reveals a direct link between the Hippo and mTORC1 pathways in the control of tumour growth.